Global Cannabis Pharmaceuticals 麻豆原创 Research Report 2024

Publication ID:

PB510246812

Publication Date:

October 30, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Cannabis pharmaceuticals refers to the development and sale of pharmaceutical drugs or medicines with compounds of cannabis plants acting as key components. The plant belongs to the Cannabaceae family of flowering plants and produces a highly popular psychoactive drug called marijuana or cannabis. The plant is indigenous to South and Central Asia. It is widely used as a recreational drug. However, in recent times, the pharmaceutical industry has invested heavily in exploring the plant and its components for their medicinal attributes. Two of the most well-researched and popular components are cannabidiol (CBD) and tetrahydrocannabinol (THC) since they are known to exhibit several therapeutic effects. Cannabis pharmaceuticals deal with exploring a combination of cannabinoids and studying their impact on diseases or health conditions under a controlled environment and in the guidance of a licensed supervisor such as a medical practitioner. Medicines produced using cannabis are available in several forms including sprays, capsules, and tablets. The medicines cannot be rolled out in the commercial market without receiving necessary approvals from regulatory bodies.
The global Cannabis Pharmaceuticals market was valued at US$ 1156 million in 2023 and is anticipated to reach US$ 2865 million by 2030, witnessing a CAGR of 13.8% during the forecast period 2024-2030.
North American market for Cannabis Pharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cannabis Pharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cannabis Pharmaceuticals include Cronos Group, Jazz Pharmaceuticals, Elixinol Wellness, Trulieve, Tilray Brands, Inc., Cansortium Inc., Aurora Cannabis, Canopy Growth, Cresco Labs, Organigram, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cannabis Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Pharmaceuticals.
The Cannabis Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cannabis Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cannabis Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cronos Group
Jazz Pharmaceuticals
Elixinol Wellness
Trulieve
Tilray Brands, Inc.
Cansortium Inc.
Aurora Cannabis
Canopy Growth
Cresco Labs
Organigram
Segment by Type
Sprays
Capsules
Tablets
Others
Segment by Application
Pharmacies
Hospitals
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cannabis Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cannabis Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Cannabis Pharmaceuticals 麻豆原创 Overview
1.1 Product Definition
1.2 Cannabis Pharmaceuticals by Type
1.2.1 Global Cannabis Pharmaceuticals 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Sprays
1.2.3 Capsules
1.2.4 Tablets
1.2.5 Others
1.3 Cannabis Pharmaceuticals by Application
1.3.1 Global Cannabis Pharmaceuticals 麻豆原创 Value by Application (2024-2030)
1.3.2 Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Global Cannabis Pharmaceuticals 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Cannabis Pharmaceuticals Revenue 2019-2030
1.4.2 Global Cannabis Pharmaceuticals Sales 2019-2030
1.4.3 Global Cannabis Pharmaceuticals 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cannabis Pharmaceuticals 麻豆原创 Competition by Manufacturers
2.1 Global Cannabis Pharmaceuticals Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Cannabis Pharmaceuticals Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Cannabis Pharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Cannabis Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cannabis Pharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cannabis Pharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of Cannabis Pharmaceuticals, Date of Enter into This Industry
2.8 Global Cannabis Pharmaceuticals 麻豆原创 Competitive Situation and Trends
2.8.1 Global Cannabis Pharmaceuticals 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Cannabis Pharmaceuticals Players 麻豆原创 Share by Revenue
2.8.3 Global Cannabis Pharmaceuticals 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cannabis Pharmaceuticals 麻豆原创 Scenario by Region
3.1 Global Cannabis Pharmaceuticals 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cannabis Pharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Cannabis Pharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Cannabis Pharmaceuticals Sales by Region: 2025-2030
3.3 Global Cannabis Pharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Cannabis Pharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Cannabis Pharmaceuticals Revenue by Region: 2025-2030
3.4 North America Cannabis Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.4.1 North America Cannabis Pharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Cannabis Pharmaceuticals Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cannabis Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.5.1 Europe Cannabis Pharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Cannabis Pharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cannabis Pharmaceuticals 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Cannabis Pharmaceuticals 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cannabis Pharmaceuticals Sales by Region (2019-2030)
3.6.3 Asia Pacific Cannabis Pharmaceuticals Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cannabis Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Cannabis Pharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Cannabis Pharmaceuticals Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cannabis Pharmaceuticals 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Cannabis Pharmaceuticals 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cannabis Pharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cannabis Pharmaceuticals Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cannabis Pharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Cannabis Pharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Cannabis Pharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Cannabis Pharmaceuticals Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Cannabis Pharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Cannabis Pharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Cannabis Pharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Cannabis Pharmaceuticals Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Cannabis Pharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cannabis Pharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Cannabis Pharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Cannabis Pharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Cannabis Pharmaceuticals Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Cannabis Pharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Cannabis Pharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Cannabis Pharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Cannabis Pharmaceuticals Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Cannabis Pharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Cronos Group
6.1.1 Cronos Group Company Information
6.1.2 Cronos Group Description and Business Overview
6.1.3 Cronos Group Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Cronos Group Cannabis Pharmaceuticals Product Portfolio
6.1.5 Cronos Group Recent Developments/Updates
6.2 Jazz Pharmaceuticals
6.2.1 Jazz Pharmaceuticals Company Information
6.2.2 Jazz Pharmaceuticals Description and Business Overview
6.2.3 Jazz Pharmaceuticals Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jazz Pharmaceuticals Cannabis Pharmaceuticals Product Portfolio
6.2.5 Jazz Pharmaceuticals Recent Developments/Updates
6.3 Elixinol Wellness
6.3.1 Elixinol Wellness Company Information
6.3.2 Elixinol Wellness Description and Business Overview
6.3.3 Elixinol Wellness Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elixinol Wellness Cannabis Pharmaceuticals Product Portfolio
6.3.5 Elixinol Wellness Recent Developments/Updates
6.4 Trulieve
6.4.1 Trulieve Company Information
6.4.2 Trulieve Description and Business Overview
6.4.3 Trulieve Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Trulieve Cannabis Pharmaceuticals Product Portfolio
6.4.5 Trulieve Recent Developments/Updates
6.5 Tilray Brands, Inc.
6.5.1 Tilray Brands, Inc. Company Information
6.5.2 Tilray Brands, Inc. Description and Business Overview
6.5.3 Tilray Brands, Inc. Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tilray Brands, Inc. Cannabis Pharmaceuticals Product Portfolio
6.5.5 Tilray Brands, Inc. Recent Developments/Updates
6.6 Cansortium Inc.
6.6.1 Cansortium Inc. Company Information
6.6.2 Cansortium Inc. Description and Business Overview
6.6.3 Cansortium Inc. Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cansortium Inc. Cannabis Pharmaceuticals Product Portfolio
6.6.5 Cansortium Inc. Recent Developments/Updates
6.7 Aurora Cannabis
6.7.1 Aurora Cannabis Company Information
6.7.2 Aurora Cannabis Description and Business Overview
6.7.3 Aurora Cannabis Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Aurora Cannabis Cannabis Pharmaceuticals Product Portfolio
6.7.5 Aurora Cannabis Recent Developments/Updates
6.8 Canopy Growth
6.8.1 Canopy Growth Company Information
6.8.2 Canopy Growth Description and Business Overview
6.8.3 Canopy Growth Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Canopy Growth Cannabis Pharmaceuticals Product Portfolio
6.8.5 Canopy Growth Recent Developments/Updates
6.9 Cresco Labs
6.9.1 Cresco Labs Company Information
6.9.2 Cresco Labs Description and Business Overview
6.9.3 Cresco Labs Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cresco Labs Cannabis Pharmaceuticals Product Portfolio
6.9.5 Cresco Labs Recent Developments/Updates
6.10 Organigram
6.10.1 Organigram Company Information
6.10.2 Organigram Description and Business Overview
6.10.3 Organigram Cannabis Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Organigram Cannabis Pharmaceuticals Product Portfolio
6.10.5 Organigram Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cannabis Pharmaceuticals Industry Chain Analysis
7.2 Cannabis Pharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cannabis Pharmaceuticals Production Mode & Process
7.4 Cannabis Pharmaceuticals Sales and 麻豆原创ing
7.4.1 Cannabis Pharmaceuticals Sales Channels
7.4.2 Cannabis Pharmaceuticals Distributors
7.5 Cannabis Pharmaceuticals Customers
8 Cannabis Pharmaceuticals 麻豆原创 Dynamics
8.1 Cannabis Pharmaceuticals Industry Trends
8.2 Cannabis Pharmaceuticals 麻豆原创 Drivers
8.3 Cannabis Pharmaceuticals 麻豆原创 Challenges
8.4 Cannabis Pharmaceuticals 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Cronos Group
Jazz Pharmaceuticals
Elixinol Wellness
Trulieve
Tilray Brands, Inc.
Cansortium Inc.
Aurora Cannabis
Canopy Growth
Cresco Labs
Organigram

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.